The Patent Finder
IM

Indi Molecular, Inc.

First filing 2012
OverviewNotableFeesChangesFamiliesPatent listSources & methods

3 patents currently held

16 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1 more record may belong here and awaits a decision; it is not counted.

The next term ends in Nov 2039. from the record

Of the 16 now held by other companies, 15 name Regeneron Pharmaceuticals Inc. as their current owner, and 1 more name another party. Each row says which.

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Nov 2039
Next term end
3
Patent families

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
notable patents all others Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank

Formerly held, still cited

Notable
Cited by 18 later US patents, top 25% of utility patents granted in 2018 in our data, and renewed at every maintenance window due so far. Protection runs to 2036.
Ends Mar 2036 · High confidence
Also notable
The most cited patent in this portfolio, cited by 21 later US patents, top 25% of utility patents granted in 2016 in our data. Protection runs to 2034.
Ends Mar 2034 · High confidence

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Feb 22, 2027
    The maintenance fee for Compositions, Imaging, and Therapeutic Methods Targeting Folate Receptor 1 (FOLR1) (US 11,733,246) comes due Feb 22, 2027. Unpaid by Aug 23, 2027, it lapses early.
  • 1 fee due Mar 26, 2027
    The maintenance fee for Compositions, Delivery Systems, and Methods Useful in Tumor Therapy (US 11,766,414) comes due Mar 26, 2027. Unpaid by Sep 27, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

What they patent

The 2 largest of its 3 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.

Showing 1 to 3 of 3

PatentTitleStatusExpiresConfidence
US 11,638,764Theranostic Capture Agents, Compositions, and Methods of Using and Making
In force
 · High confidence
In forceHigh confidence
US 11,733,246Compositions, Imaging, and Therapeutic Methods Targeting Folate Receptor 1 (FOLR1)
In force
 · Low confidence
In forceLow confidence
US 11,766,414Compositions, Delivery Systems, and Methods Useful in Tumor Therapy
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 3: 16 patents in force now held by others · 6 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited